Pro Football Legends, the commercial marketing arm of the National
Football League Alumni, Inc. (NFL Alumni) and Laboratory Corporation of
America® Holdings (LabCorp®) (NYSE: LH) are
pleased to announce that they have entered into an agreement for LabCorp
to be a sponsor of Pro Football Legends. Under this agreement, LabCorp
will offer to provide diagnostic testing services for NFL Alumni members
and their families.
“This partnership tackles one of our highest priorities, which is
helping our members manage their health needs,” said Joseph Pisarcik,
President and CEO of the NFL Alumni. “Having been a LabCorp patient for
many years, I couldn’t be more excited about forging this relationship
for the benefit of our NFL Alumni members and their families.”
LabCorp will provide access to a comprehensive range of high quality
diagnostic testing services, including blood work, to NFL Alumni members
and their dependents. This arrangement for laboratory services follows
earlier NFL Alumni initiatives to make other healthcare services
available to its members, such as prostate and diabetes screening and
discounted hearing aid technology. Although many former NFL players are
healthy and financially secure, others face challenges in their
post-football lives. The NFL Alumni’s mission is to serve, assist and
inform former players and their families through medical, financial and
social programs intended to help members lead healthy, productive lives.
The LabCorp program, which begins this month with the NFL Alumni’s
Philadelphia and New York/New Jersey Chapters, will roll out nationally
to all NFL Alumni chapters in the next 60 days. Laboratory services will
be made available to NFL Alumni members and their dependents who don’t
have health insurance.
“LabCorp is excited about this partnership, and we look forward to
working with all NFL Alumni chapters across the U.S.,” said James T.
Boyle, Jr., LabCorp’s Chief Operating Officer. “LabCorp and its
employees have always been strong supporters of community-based efforts
to expand access to healthcare, in addition to giving time and resources
to support similar causes. We are pleased to implement this program with
the NFL Alumni and its members.”
About the Pro Football Legends
Pro Football Legends is the commercial marketing name and logo of the
NFL Alumni Association, a nationwide group of former National Football
League players, coaches and other employees whose mission is to serve,
assist and inform former players and their families. The association
offers a variety of medical, financial and social programs to help
members lead healthy, productive and connected lives, as well as
community initiatives under its “Caring for Kids” programs. For more
information please visit www.nflalumni.org.
About LabCorp®
Laboratory Corporation of America® Holdings, an S&P 500
company, is a pioneer in commercializing new diagnostic technologies and
the first in its industry to embrace genomic testing. With annual
revenues of $5.8 billion in 2013, over 34,000 employees worldwide, and
more than 220,000 clients, LabCorp offers more than 4,000 tests ranging
from routine blood analyses to reproductive genetics to companion
diagnostics. LabCorp furthers its scientific expertise and innovative
clinical testing technology through its LabCorp Specialty Testing Group:
The Center for Molecular Biology and Pathology, National Genetics
Institute, ViroMed Laboratories, Inc, The Center for Esoteric Testing,
Litholink Corporation, Integrated Genetics, Integrated Oncology, Dianon
Pathology, Monogram Biosciences, Inc, Colorado Coagulation, Cellmark
Forensics, MedTox, and Endocrine Sciences. LabCorp conducts clinical
trials testing through its LabCorp Clinical Trials division. LabCorp
clients include physicians, government agencies, managed care
organizations, hospitals, clinical labs, and pharmaceutical companies.
To learn more about our organization, visit our website at: www.labcorp.com.
This press release contains forward-looking statements including with
respect to estimated 2014 guidance and the impact of various factors on
operating results. Each of the forward-looking statements is subject to
change based on various important factors, including without limitation,
competitive actions in the marketplace and adverse actions of
governmental and other third-party payers. Actual results could
differ materially from those suggested by these forward-looking
statements. Further information on potential factors that could affect
LabCorp’s operating and financial results is included in the Company’s
Form 10-K for the year ended December 31, 2013, including under the
heading risk factors, and in the Company’s other filings with the SEC.
The information in this press release should be read in conjunction
with a review of the Company’s filings with the SEC including the
information in the section of the Company’s Form 10-K for the year ended
December 31, 2013 and subsequent Forms 10-Q under the heading
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141217005069/en/
Copyright Business Wire 2014